thrombophlebitis - Nursing Case Study
Pathophysiology
• Primary mechanism: Vessel injury triggers endothelial dysfunction, leading to platelet aggregation and the activation of the coagulation cascade, forming a thrombus in the vein.
• Secondary mechanism: Inflammation at the site of the thrombus causes swelling and pain, while the vein wall thickens due to infiltration of inflammatory cells, exacerbating blood flow obstruction.
• Key complication: If the thrombus dislodges, it may lead to embolism, potentially resulting in serious conditions such as pulmonary embolism, emphasizing the need for prompt diagnosis and management.
Patient Profile
Demographics:
53-year-old female, office worker
History:
• Key past medical history: History of varicose veins and previous episodes of superficial thrombophlebitis
• Current medications: Aspirin 81 mg daily, Atorvastatin 20 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Pain and swelling in the left leg
• Key symptoms: Redness and warmth along a vein in the left leg, mild fever, and tenderness to touch
• Vital signs: Temperature 100.4°F (38°C), Blood Pressure 140/90 mmHg, Heart Rate 95 bpm, Respiratory Rate 18 breaths/min
Section 1
New Diagnostic Results:
As the medical team proceeds with further diagnostic evaluations, a Doppler ultrasound of the left leg is performed to assess the extent of thrombosis and to rule out deep vein thrombosis (DVT), a more concerning condition. The ultrasound reveals a superficial thrombus in the great saphenous vein, with no evidence of deep vein involvement. However, the presence of a superficial thrombus near the saphenofemoral junction raises concerns due to its proximity to deep venous structures, potentially increasing the risk of embolization.
In parallel, blood tests are conducted to evaluate the patient's inflammatory status and coagulation profile. The results indicate an elevated D-dimer level, which is consistent with the presence of a thrombus and heightened fibrinolytic activity. The complete blood count shows a mild leukocytosis, aligned with the inflammatory response, while the coagulation panel remains within normal limits, suggesting no significant systemic coagulation disorder at this time. These findings necessitate careful monitoring and prompt initiation of appropriate anticoagulation therapy to prevent further complications, such as the progression to deep vein thrombosis or pulmonary embolism.
The medical team decides to initiate low molecular weight heparin (LMWH) to manage the thrombophlebitis and reduce the risk of thrombus propagation. Additionally, the patient is advised to elevate the affected leg, apply warm compresses, and continue wearing compression stockings to improve venous return and alleviate symptoms. The case now requires ongoing assessment to ensure that the intervention is effective and to monitor for any new complications that might arise, such as increased pain, swelling, or signs of embolic events. Regular re-evaluation and patient education on recognizing symptoms of potential complications will be critical in this patient's continued care.
Section 2
As the patient progresses under the current treatment regimen, a change in status necessitates further evaluation. On the third day of hospitalization, the patient reports increased pain and swelling in the left leg despite adherence to the prescribed interventions. A physical examination reveals a notable increase in erythema and tenderness along the affected vein, extending slightly beyond the initial area of involvement. The patient's vital signs indicate a low-grade fever of 100.4°F, a blood pressure of 130/85 mmHg, heart rate of 92 beats per minute, respiratory rate of 20 breaths per minute, and oxygen saturation of 96% on room air. These findings suggest a possible progression or complication of the current condition.
Given these new developments, the medical team orders repeat diagnostic imaging to reassess the thrombus and evaluate for any signs of propagation. A follow-up Doppler ultrasound is performed, revealing that the thrombus has extended further towards the deep venous system, although there is still no definitive evidence of deep vein thrombosis. Concerned about the potential for embolization, the team considers adjusting the current anticoagulation strategy.
In response to the clinical changes, the team discusses the possibility of transitioning from low molecular weight heparin to an oral anticoagulant such as a direct oral anticoagulant (DOAC) for longer-term management. This approach could offer better control of the thrombus while reducing the risk of complications. The patient is educated on the importance of continued monitoring for symptoms such as sudden chest pain or shortness of breath, which would necessitate immediate medical attention. The medical team emphasizes the need for close follow-up, both in the hospital setting and after discharge, to ensure a successful outcome and prevent further thromboembolic events.
Section 3
As the patient continues under the adjusted treatment plan, the medical team closely monitors for any signs of improvement or further complications. Despite the transition to a direct oral anticoagulant (DOAC), the patient reports new symptoms on the fourth day of hospitalization, including mild shortness of breath and a sense of tightness in the chest. These symptoms prompt the team to act swiftly due to the potential risk of pulmonary embolism, a known complication of thrombus propagation.
A repeat set of vital signs shows a slightly elevated heart rate of 100 beats per minute and a respiratory rate of 22 breaths per minute, while blood pressure remains stable at 128/84 mmHg. Oxygen saturation has decreased to 94% on room air, raising further suspicion of compromised pulmonary function. Given these clinical changes, the team orders an urgent CT pulmonary angiography to assess for pulmonary embolism. Laboratory tests are also obtained, including D-dimer levels, which return elevated, supporting the likelihood of thromboembolic activity.
The CT scan confirms the presence of a small embolus in the right lower lobe pulmonary artery. This finding corroborates the clinical symptoms and necessitates an immediate adjustment in the treatment approach. The medical team discusses the results with the patient, emphasizing the importance of adhering to the anticoagulation therapy and the need for vigilant symptom monitoring. The plan includes increased frequency of vital sign monitoring and potential escalation of care if the patient’s respiratory status deteriorates further. These steps are crucial in managing the newly developed complication and preventing any significant adverse outcomes.
Section 4
Following the confirmation of a pulmonary embolism, the medical team implements an enhanced monitoring protocol for the patient, focusing on respiratory and cardiovascular status. Over the next 24 hours, the patient's vital signs are closely tracked, revealing a slight but notable increase in respiratory distress. The patient's respiratory rate climbs to 26 breaths per minute, and the heart rate rises to 108 beats per minute, with oxygen saturation fluctuating between 92% and 93% on room air. These changes prompt the nursing team to initiate supplemental oxygen therapy, starting with a nasal cannula set at 2 liters per minute, which stabilizes oxygen saturation at around 95%.
Despite these interventions, the patient begins to report increased fatigue and exhibits mild cyanosis around the lips. The medical team evaluates the need for further diagnostic work-up, considering potential complications such as right ventricular strain due to the embolus. An echocardiogram is scheduled to assess cardiac function and potential right heart involvement. Concurrently, repeat blood tests, including arterial blood gases, show a mild respiratory alkalosis with a pH of 7.47 and a partial pressure of carbon dioxide (PaCO2) at 32 mmHg, reflecting the patient's compensatory hyperventilation.
The clinical team convenes to discuss the evolving situation and decides to titrate the anticoagulation therapy, ensuring therapeutic levels are achieved swiftly to prevent further thromboembolic events. The patient's family is updated on the current status and the importance of adhering to the treatment plan is reiterated. The team emphasizes the need for the patient to alert staff to any worsening symptoms, such as increased chest pain or significant shortness of breath. These proactive measures aim to optimize the patient's recovery trajectory while minimizing the risk of further complications. The situation underscores the critical need for ongoing assessment and timely intervention in managing thromboembolic diseases.
Section 5
As the patient continues under close observation, a new development arises. Despite initial stabilization with supplemental oxygen, the patient's respiratory status shows further decline. The respiratory rate increases to 30 breaths per minute, and the patient reports a sudden onset of sharp, pleuritic chest pain. The nursing team promptly reassesses the patient, noting the persistence of mild cyanosis and the emergence of bilateral crackles on auscultation. These findings raise suspicion of potential pulmonary complications, such as pulmonary edema or evolving pneumonia, secondary to the underlying pulmonary embolism.
In response to these changes, the medical team orders a chest X-ray, which reveals bilateral infiltrates consistent with pulmonary congestion. Additionally, the echocardiogram results confirm evidence of right ventricular strain, highlighting the significant hemodynamic impact of the embolus. The arterial blood gas analysis is repeated, showing worsening respiratory alkalosis with a pH of 7.50 and a further decreased PaCO2 of 28 mmHg, indicative of increased hyperventilation in response to hypoxemia.
Armed with this new information, the clinical team revises the management plan. The decision is made to escalate the level of care, transitioning the patient to a high-flow oxygen delivery system to alleviate respiratory distress and improve oxygenation. A diuretic is considered to manage potential fluid overload and relieve pulmonary congestion. The anticoagulation therapy is carefully monitored, with adjustments made to maintain therapeutic levels. These interventions aim to address the acute complications while reinforcing the importance of vigilant monitoring and prompt adaptation of the treatment strategy. The patient's family is updated on these developments, with reassurance that every measure is being taken to support recovery and prevent further deterioration. This progression in the case emphasizes the dynamic nature of thromboembolic conditions and the critical role of responsive, multidisciplinary care.